Strides Arcolab’s arm receives US FDA approval for Zoledronic Acid

06 Mar 2013 Evaluate

Agila Specialties, a wholly owned subsidiary of Strides Arcolab has received ANDA approval for Zoledronic Acid Injection 4 mg (base)/ 5ml packaged in Single dose vials. Zoledronic Acid is used to treat high blood calcium levels (hypercalcemia) that may occur with cancer.

According to IMS data, the US market for Zoledronic Acid 5ML is approximately $520 million. The product is expected to be launched shortly.

Strides Arcolab is a global pharmaceutical company headquartered in Bangalore, India that develops and manufactures wide range of IP-lead niche pharmaceutical products with an emphasis on sterile injectables.

Strides Pharma Scien Share Price

862.85 -15.80 (-1.80%)
08-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1795.30
Dr. Reddys Lab 1267.15
Cipla 1497.45
Zydus Lifesciences 924.35
Lupin 2071.35
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×